Product NDC: | 68210-0400 |
Proprietary Name: | NAPROXEN SODIUM |
Non Proprietary Name: | NAPROXEN SODIUM |
Active Ingredient(s): | 220 mg/1 & nbsp; NAPROXEN SODIUM |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68210-0400 |
Labeler Name: | SPIRIT PHARMACEUTICALS,LLC |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | ANDA090545 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110801 |
Package NDC: | 68210-0400-0 |
Package Description: | 15 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68210-0400-0) |
NDC Code | 68210-0400-0 |
Proprietary Name | NAPROXEN SODIUM |
Package Description | 15 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68210-0400-0) |
Product NDC | 68210-0400 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | NAPROXEN SODIUM |
Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20110801 |
Marketing Category Name | ANDA |
Labeler Name | SPIRIT PHARMACEUTICALS,LLC |
Substance Name | NAPROXEN SODIUM |
Strength Number | 220 |
Strength Unit | mg/1 |
Pharmaceutical Classes |